novo glp 1 drugs GLP-1 may have a beneficial effect across many types of cancer GLP-1 Drugs Are Coming, and

A systematic review with meta-analysis on 33 data sets with at least 10 years follow up, including a single center with 20 years of follow-up, found significant and sustained weight loss after surgery

Always consult with a licensed clinician to ensure your treatment plan is tailored to your unique medical history, maximizing benefits while minimizing these potential complications

The potent and reliable metabolic effects, coupled with ease of administration, make Ozempic the leading GLP-1 product globally, capturing the largest market share

Improves blood sugar control and reduces cardiovascular risk

doi:10.1111/dom.14831 175

Here, we discuss results from Wave 12, conducted in February 2025